ArticlePharmaceutics2022

Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells.

Shaimaa M Badr-Eldin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.